Charcot-Marie-Tooth Association Newsroom Press Releases

Published on September 23, 2025 - 11:00 GMT

CMTA Invests $281,339 to Advance Treatments for CMT1A

CMTA invests $281,339 in a new therapeutic pathway to accelerate treatments for CMT1A. GLENOLDEN, PA, UNITED STATES, September 23, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie- …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on May 19, 2025 - 14:00 GMT

CMTA Presents New Genetic Landscape Analysis at The 2025 Annual Meeting of the Peripheral Nerve Society

CMTA presents findings at PNS 2025, revealing 135 CMT genes and 169 subtypes, highlighting the need for continued research to improve diagnosis and care. GLENOLDEN, PA, UNITED STATES, May 19, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on May 12, 2025 - 11:00 GMT

CMTA-INC Alliance Announces 2025 Inherited Neuropathy Fellowship Recipient

Orthopedic Surgeon to Focus on Improving Outcomes for People with CMT GLENOLDEN, PA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on April 22, 2025 - 11:00 GMT

CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery

New CMTA-STAR project aims to uncover elusive mutations in CMT through long-read sequencing, helping more patients reach a genetic diagnosis. GLENOLDEN, PA, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA), …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on March 25, 2025 - 11:00 GMT

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA), the …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on March 18, 2025 - 11:00 GMT

CMTA Fuels Breakthrough Imaging Research to Address CMT2A’s Cellular Weakness

CMTA funds $90,860 research using AI-driven imaging to track cellular defects in CMT2A, accelerating therapeutic discovery for this axonal form of CMT. GLENOLDEN, PA, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on February 4, 2025 - 12:00 GMT

CMTA Invests $423K in Transformative Genomic Research to Advance CMT Diagnostics

CMTA invests $423K in genomic research to close CMT diagnostic gaps, advance gene discovery, and expand the GENESIS platform, driving progress toward a cure. GLENOLDEN, PA, UNITED STATES, February 4, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on June 20, 2024 - 11:00 GMT

The Charcot-Marie-Tooth Association Appoints David Skarinsky to its Therapy Expert Board

David Skarinsky, with over 35 years of clinical development experience, joins CMTA's Therapy Expert Board to accelerate CMT research and treatments. GLENOLDEN, PENNSYLVANIA, UNITED STATES, June 20, 2024 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on June 18, 2024 - 11:00 GMT

CMTA's $240K Investment Targets Gene Replacement Therapy in CMT4 Subtypes

CMTA announces $240K investment in gene therapy for CMT4A, pioneering treatment with potential for other CMT types. GLENOLDEN, PENNSYLVANIA, UNITED STATES, June 18, 2024 /⁨EINPresswire.com⁩/ -- CMTA's $240K Investment Targets Gene Replacement Therapy …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on April 2, 2024 - 12:57 GMT

CMTA's $450K Investment Targets New Approach to Treatment for Patients with CMT1A and CMT1B

Building on Previous CMTA-Funded Success, New $450K Investment Accelerates Research to Treat CMT1A and CMT1B GLENOLDEN, PENNSYLVANIA, UNITED STATES, April 2, 2024 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA), the largest …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on February 21, 2024 - 12:00 GMT

Leading the Way: The CMTA Invests More Than $200K in Cutting-Edge CMT1A Organoid Research

The CMTA's new $200K+ investment accelerates CMT1A organoid research, revolutionizing treatment evaluation for Charcot-Marie-Tooth disease (CMT) GLENOLDEN, PENNSYLVANIA, USA, February 21, 2024 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on February 13, 2024 - 12:00 GMT

The CMTA Appoints Professor Charlotte Sumner, M.D., to its Scientific Advisory Board

The Charcot-Marie-Tooth Association welcomes to its STAR Advisory Board, Dr. Charlotte Sumner, accelerating research for Charcot-Marie-Tooth disease treatments. GLENOLDEN, PENNSYLVANIA, UNITED STATES, February 13, 2024 /⁨EINPresswire.com⁩/ -- The Charcot- …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on February 7, 2024 - 12:00 GMT

CMTA Awards Over Half a Million Dollars to Fuel Research in Demyelinating Forms of CMT

New 500K+ investment by the CMTA to find new treatments for CMT types 1A and 1B to solve an unmet need. GLENOLDEN, PA, UNITED STATES, February 7, 2024 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA) announced today a groundbreaking …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on November 14, 2023 - 14:00 GMT

CMTA Announces Participation in Seed Extension Round for Armatus Bio for Novel CMT1A Gene Therapy

First Investment from CMTA’s New Venture Philanthropy Arm GLENOLDEN, PA, USA, November 14, 2023 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA) today announced that it participated in the Seed Series Extension syndicate for Armatus Bio, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 28, 2023 - 13:00 GMT

CMTA Awards $225,483 for Study on Using ASOs to Treat CMT2E

GLENOLDEN, PA, USA, September 28, 2023 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA) Board of Directors announced Sept. 28 that it has approved a $225,483 award to Dr. Mario Saporta at the University of Miami for a study on the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 12, 2023 - 13:49 GMT

MDA, CMTA Announce Grant for Collaborative Non-Viral Gene Therapy Research on CMT1X

GLENOLDEN, PA, USA, September 12, 2023 /⁨EINPresswire.com⁩/ -- The Muscular Dystrophy Association (MDA) and Charcot-Marie-Tooth Association (CMTA) today announced a collaborative research grant totaling $299,992 to test gene delivery to Schwann cells using …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 7, 2023 - 15:49 GMT

CMTA Updates List of Neurotoxic Meds Potentially More Hazardous to CMT Patients

GLENOLDEN, PA, USA, June 7, 2023 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA) June 7 announced the results of a review of its long-running list of medications known or suspected of being toxic to the peripheral nervous system. With …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 1, 2023 - 00:00 GMT

CMTA Joins Forces with European CMT Federation To Collaborate on Research, Awareness

GLENOLDEN, PA, USA, May 31, 2023 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA) Board of Directors voted May 15 to formalize its relationship with the European CMT Federation (ECMTF). Previously a partner and collaborator, the CMTA is …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 10, 2023 - 14:00 GMT

Tech Entrepreneur Brings Enthusiasm, Business Track Record to CMTA Board

GLENOLDEN, PA, USA, May 10, 2023 /⁨EINPresswire.com⁩/ -- Tech entrepreneur David Apple joined the CMTA Board of Directors on April 25, saying he is thrilled to become part of the generation that will find treatments and cures for CMT. CMT is a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 27, 2023 - 13:43 GMT

Sperm Donor with Gene for Charcot-Marie-Tooth Disease Passes It on to Multiple Families

GLENOLDEN, PA, USA, April 27, 2023 /⁨EINPresswire.com⁩/ -- The letter from the sperm bank landed like a bomb in the midst of the families who had conceived children with Donor X: He had tested positive for one of the genes that cause Charcot-Marie-Tooth …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

The Newsroom of Charcot-Marie-Tooth Association